MedTrace Logo

Influence of Acetylsalicylic Acid and Low Molecular Weight Heparins on the Incidence of Renal Hematoma of Shockwave Lithotripsy

NCT02875717 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2016-08-23

No results posted yet for this study

Summary

Retrospective Analysis of patients that received shockwave lithotripsy as Treatment of ureteral or kidney Stones. Condition examinated is the effect of low molecular weight Heparins and acetylsalicylic acid on the Formation of renal hematoma after shockwave lithotripsy. Primary outcome is documented hematoma in a postoperative ultrasound control. Secondary outcomes are perioperative complication, Need for erythrocyte tranfusion, interventions for bleeding control, readmission or death within 30 days.

Conditions

  • Urolithiasis
  • Renal Hematoma

Interventions

DRUG

Acetylsalicylic acid

DRUG

low molecular weight heparin

Sponsors & Collaborators

  • Kantonsspital Winterthur KSW

    lead OTHER

Principal Investigators

  • Hubert John, M.D. · Kantonsspital Winterthur KSW

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • Switzerland

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02875717 on ClinicalTrials.gov